Manolio, Teri A, Hutter, Carolyn M, Avigan, Mark, Cibotti, Ricardo, Davis, Robert L, Denny, Joshua C, La Grenade, Lois, Wheatley, Lisa M, Carrington, Mary N, Chantratita, Wasun et al (show 20 more authors)
(2018)
Research Directions in Genetic Predispositions to Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 103 (3).
pp. 390-394.
![[img]](https://livrepository.liverpool.ac.uk/style/images/fileicons/text.png) |
Text
SJS-TEN Research Directions Text Clean resubmitted.082817.docx - Author Accepted Manuscript Download (56kB) |
|
Text
SJS-TEN Research Directions Table 1 Changes accepted resubmitted.082817.docx - Author Accepted Manuscript Download (18kB) |
|
Text
Suppl Table 1.HighRiskDrugsAlleles resubmitted.082817.docx - Author Accepted Manuscript Download (13kB) |
Abstract
Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is one of the most devastating of adverse drug reactions (ADRs) and was, until recently, essentially unpredictable. With the discovery of several risk alleles for drug-induced SJS/TEN and the demonstration of effectiveness of screening in reducing incidence, the stage is set for implementation of preventive strategies in populations at risk. Yet much remains to be learned about this potentially fatal complication of commonly used drugs.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Humans, Stevens-Johnson Syndrome, Genetic Predisposition to Disease, Necrosis, Incidence, Predictive Value of Tests, Genetic Testing |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 23 Nov 2017 10:59 |
| Last Modified: | 19 Jan 2023 06:50 |
| DOI: | 10.1002/cpt.890 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3012632 |
Dimensions
Dimensions
